As of August 28, 2026, KalVista Pharmaceuticals, Inc. (KALV) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. KalVista Pharmaceuticals, Inc. has a market capitalization of $1.43B, 53.24M shares outstanding, 185 institutional holders tracked. Stored dilution-related fields include 1.85M outstanding warrants.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for KALV.
Market Data
Market Cap$1.43B
Shares Outstanding53.24M
Float38.18M
Cash$213.77M
Debt$172.21M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 15.5% shares (2026Q1 vs prior)
185 institutional holders · 78.75M shares
#1
Venrock Adviser, LLC
6.47M shares
#2
Frazier Life Sciences Management, L.P.
4.96M shares
#3
SUVRETTA CAPITAL MANAGEMENT, LLC
4.77M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
No current FINRA short-interest record is available for this ticker.
Recent SEC Activity
xbrl
XBRL WARRANT
2026-04-01
xbrl
XBRL CONVERTIBLE
2015-12-31
4
INSIDER TRANSACTION
2026-04-20
4
INSIDER TRANSACTION
2026-04-20
4
INSIDER TRANSACTION
2026-04-20
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual KALV Dilution Snapshot
KalVista Pharmaceuticals, Inc. (KALV) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 1.9M.
- Recent SEC activity tracked for KALV: 4 on 2026-04-20; 4 on 2026-04-20; 4 on 2026-04-20.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track KALV Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KALV — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for KALV
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.